UPRVUNL - 2021: Omeprazole, clarithromycin and metronidazole is an effective combination therapy/treatment for?

UPRVUNL - 2021

Pharmacology

Easy

Appeared in: UPRVUNL - 2021

Explanation

The combination of a Proton Pump Inhibitor (Omeprazole) with two antibiotics (Clarithromycin and Metronidazole) is a standard 'triple therapy' regimen.
This regimen is specifically designed to eradicate Helicobacter pylori, a bacterium that is a major cause of peptic ulcer disease, gastritis, and certain types of stomach cancer.
Omeprazole reduces stomach acid, which improves the efficacy of the antibiotics by allowing them to work in a more neutral pH environment and by directly inhibiting the bacteria which thrive in acid.
Clarithromycin and Metronidazole are antibiotics that directly kill the H. pylori bacteria. Using two different antibiotics helps overcome and prevent resistance.

Option A: Amoebic dysentery is a parasitic infection treated with antiparasitic drugs, primarily Metronidazole, but not in combination with Omeprazole and Clarithromycin.
Option B: E. coli-induced diarrhea is a bacterial infection, but it is typically treated with different antibiotics, such as fluoroquinolones or azithromycin, and often resolves without antibiotic therapy.
Option C: Pernicious anemia is an autoimmune condition leading to Vitamin B12 deficiency. It is not an infection and is treated with Vitamin B12 supplementation, not antibiotics.

Clinical Relevance

Nursing practice connection: Knowing Pharmacotherapy for Helicobacter pylori Infection helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Patient education is a critical nursing role for this therapy. Nurses must stress the importance of completing the full 10-14 day course to prevent treatment failure and antibiotic resistance.
A key safety instruction is to advise patients to completely avoid alcohol while taking Metronidazole and for at least 48-72 hours after the last dose, due to the risk of a disulfiram-like reaction (nausea, vomiting, flushing, headache).
Nurses should educate patients on managing common side effects, such as the metallic taste from metronidazole and potential diarrhea, to improve adherence.

How to Approach the Question

First, identify the drugs mentioned in the question: Omeprazole (a PPI), Clarithromycin (a macrolide antibiotic), and Metronidazole (a nitroimidazole antibiotic).
Recognize that this is a combination of a potent acid-suppressing agent with two antibiotics.
Recall from pharmacology that such multi-drug regimens are used to treat complex or resistant infections. The most common gastrointestinal application for this specific type of 'triple therapy' is the eradication of a resilient bacterium.
Evaluate the options. H. pylori is a well-known bacterium that requires combination therapy for eradication due to the harsh stomach environment and potential for resistance.
Eliminate the other options: Amoebic dysentery is parasitic, E. coli diarrhea uses different antibiotics, and pernicious anemia is an autoimmune/deficiency state, not an infection treated this way.

Concept Tested & Keywords

Ql-ZAOZf3A5tJKO73O36nm

E6 Medicine Harrison 22e Part 1 p. 1343-1345

E6 Pharmacology KD Tripathi Essentials 9e Part 2 p. 331-333

E6 Medicine Harrison 22e Part 2 p. 431-433